Thanks ds, the posts on 4 January have been most helpful.
The Pivot to the Platform strategy doesn't make a whole lot of sense unless one has a deep knowledge of Phylogica going back to the days of Doug Wilson and his original vision for the company. News about the continuing importance of the iMYC program would most certainly be reassuring particularly for those investors who have followed its progress since inception.
Ann: Appointment of Non-Executive Director and Appendix 3X, page-34
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58344 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |